📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial. (2023)

First Author: Writing Committee For The REMAP-CAP Investigators

Attributed to: HOD2: Instrumental Variable approaches for estimating heterogeneity of treatment effects to inform personalisation using electronic health records funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1001/jama.2023.4480

PubMed Identifier: 37039790

Publication URI: http://europepmc.org/abstract/MED/37039790

Type: Journal Article/Review

Volume: 329

Parent Publication: JAMA

Issue: 14

ISSN: 0098-7484